Xingtai Jiachuang Technology
Ordered peptides from Xingtai Jiachuang Technology? Mail in a sample (US only) and let us test it.
Test my supplyXingtai Jiachuang Technology's purity-focus evidence is fairly current and broad, led by Retatrutide's steady identity and high-purity results after one overfill miss. Tirzepatide recovered from earlier purity and identity failures, while Tesamorelin remains weaker with repeated sub-99.5% purity results and recurring batch-ID gaps.
Registry and platform records recast Jiachuang as a new small Hebei entity, not the established facility its marketing describes. The report follows a 35.com storefront, Hong Kong WhatsApp channels, copied GlobalSources boilerplate, and Xingtai cluster leads.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Xingtai Jiachuang Technology rows.
Cancel anytime
Ordered peptides from Xingtai Jiachuang Technology? Mail in a sample (US only) and let us test it.
Test my supply| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
16 Sep 2026 | Pass | Tirzepatide Xingtai Jiachuang Technology | lab name | View COA | |||
16 Sep 2026 | Pass | Retatrutide Xingtai Jiachuang Technology | lab name | View COA | |||
15 Sep 2026 | Pass | GHK-Cu Xingtai Jiachuang Technology | lab name | View COA | |||
26 Aug 2026 | Fail | Retatrutide Xingtai Jiachuang Technology | lab name | View COA | |||
15 Aug 2026 | Pass | Retatrutide Xingtai Jiachuang Technology | lab name | View COA | |||
3 Aug 2026 | Pass | GHK-Cu Xingtai Jiachuang Technology | lab name | View COA | |||
20 Jul 2026 | Pass | GHK-Cu Xingtai Jiachuang Technology | lab name | View COA | |||
20 Jul 2026 | Pass | Tirzepatide Xingtai Jiachuang Technology | lab name | View COA | |||
20 Jul 2026 | Pass | GHK-Cu Xingtai Jiachuang Technology | lab name | View COA | |||
13 Jul 2026 | Fail | Retatrutide Xingtai Jiachuang Technology | lab name | View COA | |||
About Xingtai Jiachuang Technology test results from Finnrick
Xingtai Jiachuang Technology is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 5 peptides and 68 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Xingtai Jiachuang Technology peptides in this dataset are BPC-157 (3 tests), GHK-Cu (7 tests) and Retatrutide (19 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 68 recent tests. It also includes 1 correction related to this vendor.
Ordered peptides from Xingtai Jiachuang Technology? Mail in a sample (US only) and let us test it.
Test my supply